Total words: 1657 | 2-word phrases: 443 | 3-word phrases: 481 | 4-word phrases: 498
Title | Try to keep the title under 60 characters (47 characters) OXLUMO® (lumasiran) | Official Patient Website |
Description | Try to keep the meta description between 50 - 160 characters (226 characters) OXLUMO® (lumasiran) is the first FDA-approved prescription medication for the treatment of primary hyperoxaluria type 1 (PH1) by lowering oxalate in urine. See Important Safety Information on risk of injection site reactions. |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | H1 tag on the page (103 characters) The first FDA-approved prescription medication for the treatment of primary hyperoxaluria type 1 (PH1). |
# | Keyword | H1 | Title | Des | Volume | Position | Suggest | Frequency | Density |
---|---|---|---|---|---|---|---|---|---|
1 | to | 19 | 8.09% | ||||||
2 | and | 14 | 5.96% | ||||||
3 | are | 13 | 5.53% | ||||||
4 | of | 13 | 5.53% | ||||||
5 | alnylam | 12 | 5.11% | ||||||
6 | oxlumo | 12 | 5.11% | ||||||
7 | the | 12 | 5.11% | ||||||
8 | site | 11 | 4.68% | ||||||
9 | is | 10 | 4.26% | ||||||
10 | for | 10 | 4.26% |
# | URL | Whois | Check |
---|---|---|---|
1 | https://www.alnylam.com/oxlumo-us-prescribing-information | Whois | alnylam.com |
2 | https://www.oxlumohcp.com | Whois | oxlumohcp.com |
3 | https://www.alnylam.com/oxlumo-us-prescribing-information | Whois | alnylam.com |
4 | https://www.oxlumohcp.com | Whois | oxlumohcp.com |
5 | https://www.oxlumohcp.com/ | Whois | oxlumohcp.com |
6 | https://www.fda.gov/medwatch | Whois | fda.gov |
7 | https://www.alnylam.com/oxlumo-us-prescribing-information | Whois | alnylam.com |
8 | https://www.alnylam.com | Whois | alnylam.com |
9 | https://alnylampolicies.com/privacy | Whois | alnylampolicies.com |
10 | https://alnylampolicies.com/legal | Whois | alnylampolicies.com |
11 | https://www.alnylam.com/contact-us/ | Whois | alnylam.com |